| Source | Latest linked headline | Age |
|---|---|---|
| NPR Topics: News | KALSHI AND POLYMARKET BETS ON CLINICAL TRIALS CRITICIZED AS 'GHASTLY' | 1 hr ago |
Researchers warn betting on clinical trials could incentivize insider trading and interfere with drug development. But Kalshi and Polymarket say they provide valuable information to patients.
NPR Topics: News reports that researchers warn betting on clinical trials could incentivize insider trading and interfere with drug development.
The report adds: But Kalshi and Polymarket say they provide valuable information to patients.
This is a developing report. DAMMNEWS will surface related coverage as closely matched reporting enters the live cache.
DAMMNEWS RSS BRIEFING — generated locally from the available NPR Topics: News headline and RSS excerpt. It is not a summary of the full source article.